REFERENCES
1. Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH. Chronic hypertension and adverse pregnancy outcome: a cohort study.Ultrasound Obstet Gynecol . 2017;50(2):228-35.
2. Nzelu D, Dumitrascu-Biris D, Nicolaides KH, Kametas NA. Chronic hypertension: first-trimester blood pressure control and likelihood of severe hypertension, preeclampsia, and small for gestational age.Am J Obstet Gynecol . 2018;218(3):337.e1-.e7.
3. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol . 2014;10(8):466-80.
4. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The ”Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol . 2011;204(3):193-201.
5. Akolekar R, Zaragoza E, Poon L, Pepes S, Nicolaides K. Maternal serum placental growth factor at 11+ 0 to 13+ 6 weeks of gestation in the prediction of pre‐eclampsia. Ultrasound in Obstetrics and Gynecology . 2008;32(6):732-9.
6. O’Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation.Ultrasound Obstet Gynecol . 2017;49(6):751-5.
7. Wright A, Wright D, Syngelaki A, Georgantis A, Nicolaides KH. Two-stage screening for preterm preeclampsia at 11-13 weeks’ gestation.Am J Obstet Gynecol . 2019;220(2):197.e1-.e11.
8. Felmeden DC, Spencer CG, Blann AD, Beevers DG, Lip GY. Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Intern Med . 2003;253(1):81-91.
9. Perni U, Sison C, Sharma V, Helseth G, Hawfield A, Suthanthiran M, et al. Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy.Hypertension . 2012;59(3):740-6.
10. Dinarello CA. Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases. Curr Opin Immunol . 1991;3(6):941-8.
11. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, et al. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol . 1991;260(5 Pt 2):H1713-7.
12. Schiffrin EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension . 1995;25(6):1135-43.
13. Ishizuka T, Takamizawa-Matsumoto M, Suzuki K, Kurita A. Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor alpha-stimulated vascular endothelial cells. Eur J Pharmacol . 1999;369(2):237-45.
14. Robinson H, Fleming J. A critical evaluation of sonar “crown‐rump length” measurements. BJOG: An International Journal of Obstetrics & Gynaecology . 1975;82(9):702-10.
15. Tranquilli A, Dekker G, Magee L, Roberts J, Sibai B, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP.Pregnancy Hypertens . 2014;4(2):97-104.
16. Panaitescu AM, Akolekar R, Kametas N, Syngelaki A, Nicolaides KH. Impaired placentation in women with chronic hypertension who develop pre-eclampsia. Ultrasound Obstet Gynecol . 2017;50(4):496-500.
17. Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, et al. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PloS one . 2010;5(10):e13263.
18. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens . 2005;19(2):149-54.
19. Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A. Association of cardiovascular risk factors and endothelial dysfunction in japanese hypertensive patients: implications for early atherosclerosis. Hypertens Res . 2002;25(3):475-80.
20. Ito H, Ohshima A, Tsuzuki M, Ohto N, Takao K, Hijii C, et al. Association of serum tumour necrosis factor-alpha with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women. Clin Exp Pharmacol Physiol . 2001;28(3):188-92.
21. Yoshizumi M, Perrella MA, Burnett JC, Jr., Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res . 1993;73(1):205-9.
22. O’Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest . 1993;92(2):945-51.
23. Wolff K, Nisell H, Carlstrom K, Kublickiene K, Hemsen A, Lunell NO, et al. Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia. Regul Pept . 1996;67(3):211-6.
24. Szarka A, Rigo J, Jr., Lazar L, Beko G, Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol . 2010;11:59.
25. Labarrere CA, DiCarlo HL, Bammerlin E, Hardin JW, Kim YM, Chaemsaithong P, et al. Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta. Am J Obstet Gynecol . 2017;216(3):287.e1-.e16.
26. Staff AC, Johnsen GM, Dechend R, Redman CWG. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol . 2014;101-102:120-6.
27. Widimsky J, Jr., Horky K, Dvorakova J. Plasma endothelin-1,2 levels in mild and severe hypertension. J Hypertens Suppl . 1991;9(6):S194-5.
28. Opsjln SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, et al. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol . 1993;169(2 Pt 1):397-404.
29. Lygnos MC, Pappa KI, Papadaki HA, Relakis C, Koumantakis E, Anagnou NP, et al. Changes in maternal plasma levels of VEGF, bFGF, TGF-beta1, ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes. In Vivo . 2006;20(1):157-63.